New drugs for rheumatoid arthritis
- PMID: 15329436
- DOI: 10.1056/NEJM200408263510922
New drugs for rheumatoid arthritis
Comment in
-
New drugs for rheumatoid arthritis.N Engl J Med. 2004 Dec 16;351(25):2659-61; author reply 2659-61. doi: 10.1056/NEJM200412163512522. N Engl J Med. 2004. PMID: 15602032 No abstract available.
-
New drugs for rheumatoid arthritis.N Engl J Med. 2004 Dec 16;351(25):2659-61; author reply 2659-61. N Engl J Med. 2004. PMID: 15609422 No abstract available.
Comment on
-
New drugs for rheumatoid arthritis.N Engl J Med. 2004 May 20;350(21):2167-79. doi: 10.1056/NEJMra032906. N Engl J Med. 2004. PMID: 15152062 Review. No abstract available.
-
Therapeutic strategies for rheumatoid arthritis.N Engl J Med. 2004 Jun 17;350(25):2591-602. doi: 10.1056/NEJMra040226. N Engl J Med. 2004. PMID: 15201416 Review. No abstract available.
Similar articles
-
Rheumatoid arthritis.N Engl J Med. 2004 Sep 23;351(13):1360-1; author reply 1360-1. doi: 10.1056/NEJM200409233511322. N Engl J Med. 2004. PMID: 15385669 No abstract available.
-
Adalimumab in juvenile rheumatoid arthritis.N Engl J Med. 2008 Dec 4;359(23):2495-6; author reply 2496-7. N Engl J Med. 2008. PMID: 19065749 No abstract available.
-
Disease-modifying antirheumatic drugs: enhancing efficacy by combination.Lancet. 2004 Feb 28;363(9410):670-1. doi: 10.1016/S0140-6736(04)15660-2. Lancet. 2004. PMID: 15001319 No abstract available.
-
Tumor necrosis factor inhibitors for rheumatoid arthritis.N Engl J Med. 2006 Aug 17;355(7):704-12. doi: 10.1056/NEJMct055183. N Engl J Med. 2006. PMID: 16914706 Review. No abstract available.
-
New drugs for rheumatoid arthritis.N Engl J Med. 2004 May 20;350(21):2167-79. doi: 10.1056/NEJMra032906. N Engl J Med. 2004. PMID: 15152062 Review. No abstract available.
Cited by
-
Targeting the IGF-Axis for Cancer Therapy: Development and Validation of an IGF-Trap as a Potential Drug.Cells. 2020 Apr 29;9(5):1098. doi: 10.3390/cells9051098. Cells. 2020. PMID: 32365498 Free PMC article. Review.
-
Insulin‑like growth factor axis: A potential nanotherapy target for resistant cervical cancer tumors (Review).Oncol Lett. 2023 Feb 10;25(3):128. doi: 10.3892/ol.2023.13714. eCollection 2023 Mar. Oncol Lett. 2023. PMID: 36844628 Free PMC article. Review.
-
Therapeutic Targeting of the IGF Axis.Cells. 2019 Aug 14;8(8):895. doi: 10.3390/cells8080895. Cells. 2019. PMID: 31416218 Free PMC article. Review.
-
The case of tumour necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis: a budget impact analysis.Pharmacoeconomics. 2005;23(3):289-98. doi: 10.2165/00019053-200523030-00008. Pharmacoeconomics. 2005. PMID: 15836009
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical